Latest News about ARGX

Recent news which mentions ARGX

< Previous 1 2 3 4 5 6 7 8 Next >

$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today

July 31, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023

July 31, 2023

Is Argenx Stock a Buy Now?

July 31, 2023

Earnings Outlook For argenx

July 26, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023

July 24, 2023

argenx Unusual Options Activity

July 21, 2023

Why Shares of Argenx Jumped This Week

July 21, 2023

The Latest Analyst Ratings for argenx

July 20, 2023

Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development

July 18, 2023

If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today

July 18, 2023

12 Health Care Stocks Moving In Monday's Intraday Session

July 17, 2023

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

July 17, 2023

Why Argenx Stock Is on Fire Today

July 17, 2023

You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers

July 17, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session

July 17, 2023

Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket

July 17, 2023

Why Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today?

July 17, 2023

Why Are Argenx Shares Trading Higher Today?

July 17, 2023

Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today?

July 17, 2023

Why Is Argenx (ARGX) Stock Up 27% Today?

July 17, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

July 17, 2023

Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session

July 17, 2023

This Emerging Market Could Be the Next Big Thing in Biotech

July 14, 2023

After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology

June 28, 2023

FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults

June 27, 2023

AstraZeneca Seeks Expanded Use For Soliris As First Targeted Therapy For Pediatric Patients With Autoimmune Neuromuscular Disease

June 26, 2023

Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis

June 21, 2023

10 Health Care Stocks With Whale Alerts In Today's Session

June 20, 2023

The Latest Analyst Ratings for argenx

June 07, 2023

Analyst Expectations for argenx's Future

June 07, 2023

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.